Hey amb, happy to put together some information for you, but you...

Hey amb, happy to put together some information for you, but you have to actually understand CANN doesn't run them but instead has strategic partnerships.

Current studies -
ACTRN12619001534178 - Being carried out through CANN's relationship with the Olivia Newton John Foundation (CANN is supplying all the product for this one).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352507/ another study completed between CANN's partnership with Pancare.

1. https://pubmed.ncbi.nlm.nih.gov/29125702/

2. https://pubmed.ncbi.nlm.nih.gov/31394352/

(The two studies completed on the Satipharm product now owned by CANN).

Plus the studies and research being conducted by CSIRO, La Trobe Univiversity and Agriculture Victoria all research partners of CANN.

So I can see why they have been approved to run a phase three clinical trial.

I will try and find some more for you but I haven't got time right now. On another note you always say how expensive this process is. CANN seemed to have saved some cash with these great partnerships letting someone else do the heavy lifting.

You do understand EOF will need to complete the Phase IIb study before they can move into a Phase III study? Please explain again how they are ahead.